Though this combination or single agent significantly caused the apoptosis of both KRAS mutant cancer cells and wild-type cells, it is observed that the two inhibitor’s combination obviously enhanced the ability of apoptosis induction in lung cancer cells harboring KRAS mutation. The gene discussed is KRAS; the disease is cancer.